Demographic Factors Associated with Overuse of Pap Testing
Overview
Authors
Affiliations
Background: Since 2003, U.S. Preventive Services Task Force guidelines recommend against Pap testing for women without a cervix following a hysterectomy and those aged >65 years. Few population-based studies have investigated factors associated with overuse of Pap testing in the U.S.
Purpose: To evaluate patient characteristics associated with overuse of Pap testing.
Methods: A cross-sectional study was conducted using data from the 2010 National Health Interview Survey (NHIS) for women aged ≥30 years. NHIS is a nationally representative survey that employs a random, stratified, multi-stage cluster sampling design. In 2010, the NHIS administered a Cancer Control Supplement with questions on cervical cancer screening and hysterectomy status. Conducted in 2011-2013, all analyses account for the stratification and clustering of data within the complex NHIS survey design. Multivariate logistic regression models were used in all analyses.
Results: Among women who have undergone a hysterectomy, younger age, Hispanic and black race/ethnicity, exceeding 400% of poverty level, and private health insurance coverage were significantly associated with receipt of a recent Pap test since hysterectomy. Among women aged >65 years, non-Hispanic white ethnicity, higher education level, exceeding 400% of poverty level, and no hysterectomy were significantly associated with receipt of a recent Pap test.
Conclusions: Targeted efforts to reduce unnecessary testing among older women and women with a hysterectomy in compliance with clinical recommendations for cervical cancer prevention are needed. Specific attention should be paid to privately insured women with incomes above 400% of the federal poverty level.
Narcisse M, McElfish P, Hallgren E, Pierre-Joseph N, Felix H Front Public Health. 2024; 12:1321253.
PMID: 38711762 PMC: 11070477. DOI: 10.3389/fpubh.2024.1321253.
Gerend M, Bradbury R, Harman J, Rust G J Gen Intern Med. 2021; 37(10):2475-2481.
PMID: 34379279 PMC: 9360208. DOI: 10.1007/s11606-021-07072-1.
Pang H, Chalmers K, Landon B, Elshaug A, Matelski J, Ling V JAMA Netw Open. 2021; 4(4):e215477.
PMID: 33871618 PMC: 8056282. DOI: 10.1001/jamanetworkopen.2021.5477.
Determinants for the use and de-implementation of low-value care in health care: a scoping review.
Augustsson H, Ingvarsson S, Nilsen P, von Thiele Schwarz U, Muli I, Dervish J Implement Sci Commun. 2021; 2(1):13.
PMID: 33541443 PMC: 7860215. DOI: 10.1186/s43058-021-00110-3.
Quick A, Krok-Schoen J, Stephens J, Fisher J Cancer Control. 2020; 27(1):1073274820979590.
PMID: 33291971 PMC: 8480352. DOI: 10.1177/1073274820979590.